Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$50.20 USD
+0.22 (0.44%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $50.21 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | 65.63% |
ABR | 1.22 |
Earnings ESP
|
-12.02% |
---|---|
Current Year | -1.18 |
Next Year | -1.76 |
EPS (TTM) | -0.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00M | NA | 10.39M | NA |
# of Estimates | 1 | NA | 4 | NA |
High Estimate | 1.00M | NA | 11.20M | NA |
Low Estimate | 1.00M | NA | 10.10M | NA |
Year ago Sales | 2.52M | 2.46M | 8.08M | 10.39M |
Year over Year Growth Est. | -60.32% | NA | 28.50% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.38 | -1.18 | -1.76 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.40 | -0.41 | -1.21 | -1.83 |
High Estimate | -0.27 | -0.27 | -0.94 | -1.15 |
Low Estimate | -0.41 | -0.41 | -1.41 | -2.09 |
Year ago EPS | -0.25 | -0.25 | -1.32 | -1.18 |
Year over Year Growth Est. | -48.00% | -52.00% | 10.61% | -49.64% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 5 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.38 | -1.18 | -1.76 |
7 Days Ago | -0.37 | -0.38 | -1.18 | -1.76 |
30 Days Ago | -0.36 | -0.36 | -1.17 | -1.70 |
60 Days Ago | -0.32 | -0.34 | -1.34 | -1.63 |
90 Days Ago | -0.32 | -0.34 | -1.34 | -1.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.41 | -1.22 | -2.03 |
Zacks Consensus Estimate | -0.37 | -0.38 | -1.18 | -1.76 |
Earnings ESP | -12.02% | -9.33% | -3.54% | -15.08% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.30 | -0.25 | -0.25 | NA |
Estimate | -0.32 | -0.35 | -0.37 | -0.46 | NA |
Difference | 0.21 | 0.05 | 0.12 | 0.21 | 0.15 |
Surprise | 65.63% | 14.29% | 32.43% | 45.65% | 39.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more